Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| HCC1143 | BMS-265246 | 3.16227766017 | -0.0230 | 0.11285 |
| HCC1143 | BMS-265246 | 3.16227766017 | -0.0605 | 0.11645 |
| HCC1143 | BMS-265246 | 3.16227766017 | -0.0717 | 0.10021 |
| HCC1143 | BMS-265246 | 10.0 | -0.0447 | 0.14210 |
| HCC1143 | BMS-265246 | 10.0 | -0.0571 | 0.07848 |
| HCC1143 | BMS-265246 | 10.0 | -0.0116 | 0.09289 |
| HCC1143 | Ulixertinib | 0.001 | 1.0489 | 0.00187 |
| HCC1143 | Ulixertinib | 0.001 | 0.9996 | -0.00370 |
| HCC1143 | Ulixertinib | 0.001 | 1.0744 | 0.01218 |
| HCC1143 | Ulixertinib | 0.003162278 | 0.9766 | 0.00188 |
| HCC1143 | Ulixertinib | 0.003162278 | 0.8605 | 0.01302 |
| HCC1143 | Ulixertinib | 0.003162278 | 0.8866 | -0.00671 |
| HCC1143 | Ulixertinib | 0.01 | 0.8887 | -0.00571 |
| HCC1143 | Ulixertinib | 0.01 | 0.8429 | -0.00835 |
| HCC1143 | Ulixertinib | 0.01 | 0.9324 | 0.02155 |
| HCC1143 | Ulixertinib | 0.031622777 | 0.8231 | -0.00024 |
| HCC1143 | Ulixertinib | 0.031622777 | 0.8467 | 0.01155 |
| HCC1143 | Ulixertinib | 0.031622777 | 0.8555 | 0.02129 |
| HCC1143 | Ulixertinib | 0.1 | 0.8808 | 0.00268 |
| HCC1143 | Ulixertinib | 0.1 | 0.8651 | 0.01351 |
| HCC1143 | Ulixertinib | 0.1 | 0.7912 | -0.00291 |
| HCC1143 | Ulixertinib | 0.316227766 | 0.6810 | 0.01685 |
| HCC1143 | Ulixertinib | 0.316227766 | 0.5841 | 0.01901 |
| HCC1143 | Ulixertinib | 0.316227766 | 0.6475 | 0.02641 |
| HCC1143 | Ulixertinib | 1.0 | 0.7916 | -0.00292 |